These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6345193)

  • 21. Plasma C-peptide and insulin responses to intravenous glucagon stimulation in idiopathic haemochromatosis.
    Rumbak MJ; Joffe BI; Seftel HC; Kalk WJ; Bezwoda WR; Bothwell TH
    S Afr Med J; 1987 Mar; 71(6):351-3. PubMed ID: 3551126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma insulin and C-peptide responses to oral glucose in newly diagnosed diabetics in north-western Tanzania.
    Ahren B; Corrigan CB; Alberti KG
    East Afr Med J; 1988 Dec; 65(12):847-51. PubMed ID: 3069450
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium-antagonistic effects on glucose response to glucagon in patients with non insulin-dependent diabetes mellitus and in normoglycemic subjects.
    Röjdmark S; Andersson DE; Hed R; Sundblad L
    Horm Metab Res; 1981 Dec; 13(12):664-7. PubMed ID: 7033091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
    Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S
    Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
    Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
    Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
    Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
    Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic insulin extraction in human pregnancy.
    Kühl C; Hornnes PJ; Faber OK
    Horm Metab Res; 1981 Feb; 13(2):71-2. PubMed ID: 7014408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of the radioimmunological determination of C-peptide (author's transl)].
    Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Oct; 91(19):658-62. PubMed ID: 120077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
    Vannini P; Ciavarella A; Flammini M; Forlani G; Capelli M; Cocchi V
    Int J Obes; 1982; 6(4):327-34. PubMed ID: 6752059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects.
    Bonora E; Cigolini M; Bosello O; Zancanaro C; Capretti L; Zavaroni I; Coscelli C; Butturini U
    Curr Med Res Opin; 1984; 9(1):47-51. PubMed ID: 6373159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge.
    Pun KK; Yeung CK; Ho PW; Lin HJ; Chan MK; Yeung RT
    Clin Nephrol; 1984 Apr; 21(4):235-40. PubMed ID: 6329569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between the routine 6-min. C-peptide value and the AUC after I.V. glucagon injection in NIDDM patients.
    Kølendorf K; Thorsteinsson B; Billesbølle P; Poulsen S
    Horm Metab Res; 1982 Dec; 14(12):675-6. PubMed ID: 7152483
    [No Abstract]   [Full Text] [Related]  

  • 35. [Glucagon-stimulated plasma c-peptide in diabetics. Clinical parameters in the choice of therapy?].
    Urdahl P; Jørgensen HS
    Tidsskr Nor Laegeforen; 1986 Jun; 106(16):1392-5. PubMed ID: 3529489
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of somatostatin on plasma C-peptide immunoreactivity in normal man.
    Canivet J; Brisson C; Gauvillé C
    Diabete Metab; 1977 Jun; 3(2):109-12. PubMed ID: 892126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-peptide response to glucagon in young diabetics.
    Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiological doses of glucagon cause a transient increase of the hepatic vein potassium concentration in man.
    Massara F; Cagliero E; Maccario M; Orzan F; Carini G
    Miner Electrolyte Metab; 1986; 12(2):142-6. PubMed ID: 2870423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
    Wajngot A; Roovete A; Vranić M; Luft R; Efendić S
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4432-6. PubMed ID: 6750603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.